Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation. / Laursen, Martin Frederik; Laursen, Rikke Pilmann; Larnkjær, Anni; Michaelsen, Kim F.; Bahl, Martin Iain; Licht, Tine Rask.

I: B M C Microbiology, Bind 17, 175, 2017.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Laursen, MF, Laursen, RP, Larnkjær, A, Michaelsen, KF, Bahl, MI & Licht, TR 2017, 'Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation', B M C Microbiology, bind 17, 175. https://doi.org/10.1186/s12866-017-1090-7

APA

Laursen, M. F., Laursen, R. P., Larnkjær, A., Michaelsen, K. F., Bahl, M. I., & Licht, T. R. (2017). Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation. B M C Microbiology, 17, [175]. https://doi.org/10.1186/s12866-017-1090-7

Vancouver

Laursen MF, Laursen RP, Larnkjær A, Michaelsen KF, Bahl MI, Licht TR. Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation. B M C Microbiology. 2017;17. 175. https://doi.org/10.1186/s12866-017-1090-7

Author

Laursen, Martin Frederik ; Laursen, Rikke Pilmann ; Larnkjær, Anni ; Michaelsen, Kim F. ; Bahl, Martin Iain ; Licht, Tine Rask. / Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation. I: B M C Microbiology. 2017 ; Bind 17.

Bibtex

@article{4718e87e895d4fe58669dd7666ee335e,
title = "Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation",
abstract = "BACKGROUND: Probiotics are increasingly applied to prevent and treat a range of infectious, immune related and gastrointestinal diseases. Despite this, the mechanisms behind the putative effects of probiotics are poorly understood. One of the suggested modes of probiotic action is modulation of the endogenous gut microbiota, however probiotic intervention studies in adults have failed to show significant effects on gut microbiota composition. The gut microbiota of young children is known to be unstable and more responsive to external factors than that of adults. Therefore, potential effects of probiotic intervention on gut microbiota may be easier detectable in early life. We thus investigated the effects of a 6 month placebo-controlled probiotic intervention with Bifidobacterium animalis subsp. lactis (BB-12{\circledR}) and Lactobacillus rhamnosus (LGG{\circledR}) on gut microbiota composition and diversity in more than 200 Danish infants (N = 290 enrolled; N = 201 all samples analyzed), as assessed by 16S rRNA amplicon sequencing. Further, we evaluated probiotic presence and proliferation by use of specific quantitative polymerase chain reaction (qPCR).RESULTS: Probiotic administration did not significantly alter gut microbiota community structure or diversity as compared to placebo. The probiotic strains were detected in 91.3{\%} of the fecal samples from children receiving probiotics and in 1{\%} of the placebo treated children. Baseline gut microbiota was not found to predict the ability of probiotics to establish in the gut after the 6 month intervention. Within the probiotics group, proliferation of the strains LGG{\circledR} and BB-12{\circledR} in the gut was detected in 44.7{\%} and 83.5{\%} of the participants, respectively. A sub-analysis of the gut microbiota including only individuals with detected growth of the probiotics LGG{\circledR} or BB-12{\circledR} and comparing these to placebo revealed no differences in community structure or diversity.CONCLUSION: Six months of probiotic administration during early life did not change gut microbiota community structure or diversity, despite active proliferation of the administered probiotic strains. Therefore, alteration of the healthy infant gut microbiota is not likely to be a prominent mechanism by which these specific probiotics works to exert beneficial effects on host health.TRIAL REGISTRATION: NCT02180581 . Registered 30 June 2014.",
keywords = "Probiotic intervention, LGG (trademark), BB-12 (trademark), Early life, Gut microbiota",
author = "Laursen, {Martin Frederik} and Laursen, {Rikke Pilmann} and Anni Larnkj{\ae}r and Michaelsen, {Kim F.} and Bahl, {Martin Iain} and Licht, {Tine Rask}",
note = "CURIS 2017 NEXS 217",
year = "2017",
doi = "10.1186/s12866-017-1090-7",
language = "English",
volume = "17",
journal = "B M C Microbiology",
issn = "1471-2180",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation

AU - Laursen, Martin Frederik

AU - Laursen, Rikke Pilmann

AU - Larnkjær, Anni

AU - Michaelsen, Kim F.

AU - Bahl, Martin Iain

AU - Licht, Tine Rask

N1 - CURIS 2017 NEXS 217

PY - 2017

Y1 - 2017

N2 - BACKGROUND: Probiotics are increasingly applied to prevent and treat a range of infectious, immune related and gastrointestinal diseases. Despite this, the mechanisms behind the putative effects of probiotics are poorly understood. One of the suggested modes of probiotic action is modulation of the endogenous gut microbiota, however probiotic intervention studies in adults have failed to show significant effects on gut microbiota composition. The gut microbiota of young children is known to be unstable and more responsive to external factors than that of adults. Therefore, potential effects of probiotic intervention on gut microbiota may be easier detectable in early life. We thus investigated the effects of a 6 month placebo-controlled probiotic intervention with Bifidobacterium animalis subsp. lactis (BB-12®) and Lactobacillus rhamnosus (LGG®) on gut microbiota composition and diversity in more than 200 Danish infants (N = 290 enrolled; N = 201 all samples analyzed), as assessed by 16S rRNA amplicon sequencing. Further, we evaluated probiotic presence and proliferation by use of specific quantitative polymerase chain reaction (qPCR).RESULTS: Probiotic administration did not significantly alter gut microbiota community structure or diversity as compared to placebo. The probiotic strains were detected in 91.3% of the fecal samples from children receiving probiotics and in 1% of the placebo treated children. Baseline gut microbiota was not found to predict the ability of probiotics to establish in the gut after the 6 month intervention. Within the probiotics group, proliferation of the strains LGG® and BB-12® in the gut was detected in 44.7% and 83.5% of the participants, respectively. A sub-analysis of the gut microbiota including only individuals with detected growth of the probiotics LGG® or BB-12® and comparing these to placebo revealed no differences in community structure or diversity.CONCLUSION: Six months of probiotic administration during early life did not change gut microbiota community structure or diversity, despite active proliferation of the administered probiotic strains. Therefore, alteration of the healthy infant gut microbiota is not likely to be a prominent mechanism by which these specific probiotics works to exert beneficial effects on host health.TRIAL REGISTRATION: NCT02180581 . Registered 30 June 2014.

AB - BACKGROUND: Probiotics are increasingly applied to prevent and treat a range of infectious, immune related and gastrointestinal diseases. Despite this, the mechanisms behind the putative effects of probiotics are poorly understood. One of the suggested modes of probiotic action is modulation of the endogenous gut microbiota, however probiotic intervention studies in adults have failed to show significant effects on gut microbiota composition. The gut microbiota of young children is known to be unstable and more responsive to external factors than that of adults. Therefore, potential effects of probiotic intervention on gut microbiota may be easier detectable in early life. We thus investigated the effects of a 6 month placebo-controlled probiotic intervention with Bifidobacterium animalis subsp. lactis (BB-12®) and Lactobacillus rhamnosus (LGG®) on gut microbiota composition and diversity in more than 200 Danish infants (N = 290 enrolled; N = 201 all samples analyzed), as assessed by 16S rRNA amplicon sequencing. Further, we evaluated probiotic presence and proliferation by use of specific quantitative polymerase chain reaction (qPCR).RESULTS: Probiotic administration did not significantly alter gut microbiota community structure or diversity as compared to placebo. The probiotic strains were detected in 91.3% of the fecal samples from children receiving probiotics and in 1% of the placebo treated children. Baseline gut microbiota was not found to predict the ability of probiotics to establish in the gut after the 6 month intervention. Within the probiotics group, proliferation of the strains LGG® and BB-12® in the gut was detected in 44.7% and 83.5% of the participants, respectively. A sub-analysis of the gut microbiota including only individuals with detected growth of the probiotics LGG® or BB-12® and comparing these to placebo revealed no differences in community structure or diversity.CONCLUSION: Six months of probiotic administration during early life did not change gut microbiota community structure or diversity, despite active proliferation of the administered probiotic strains. Therefore, alteration of the healthy infant gut microbiota is not likely to be a prominent mechanism by which these specific probiotics works to exert beneficial effects on host health.TRIAL REGISTRATION: NCT02180581 . Registered 30 June 2014.

KW - Probiotic intervention

KW - LGG (trademark)

KW - BB-12 (trademark)

KW - Early life

KW - Gut microbiota

U2 - 10.1186/s12866-017-1090-7

DO - 10.1186/s12866-017-1090-7

M3 - Journal article

C2 - 28818050

VL - 17

JO - B M C Microbiology

JF - B M C Microbiology

SN - 1471-2180

M1 - 175

ER -

ID: 182325358